authors
- Laccetti, AL
- Chatta, G
- Kyriakopoulos, C
- Iannotti, N
- Hotte, Sebastien
- Markowski, MC
- Pili, R
- Vuky, J
- Zhang, J
- Saad, F
- Villaluna, K
- Younginger, B
- Le Moigne, R
- Cesano, A
1813P Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2023
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal